Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis

Current pharmacologic treatments may provide limited analgesia in fibromyalgia and other chronic pain disorders. Low-dose naltrexone (LDN) has emerged as a potential analgesic option that has been minimally explored. This study aims to describe current real-world prescribing practices of LDN, to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Driver, C. Noelle, D’Souza, Ryan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135963/
https://www.ncbi.nlm.nih.gov/pubmed/37189705
http://dx.doi.org/10.3390/biomedicines11041087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135963/
https://www.ncbi.nlm.nih.gov/pubmed/37189705
http://dx.doi.org/10.3390/biomedicines11041087

Ejemplares similares